{
  "id": "605271d994d57fd87900000f",
  "type": "factoid",
  "question": "What indication has FTY720 been approved for by the FDA?",
  "ideal_answer": "FTY720 has been pproved (September 2010) by the U.S. FDA as a new treatment for multiple sclerosis (MS).",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/21456524"
  ],
  "snippets": [
    {
      "text": "Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21456524",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Fingolimod (Gilenya; FTY720), a synthetic compound based on the fungal secondary metabolite myriocin (ISP-I), is a potent immunosuppressant that was approved (September 2010) by the U.S. FDA as a new treatment for multiple sclerosis (MS). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21456524",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "multiple sclerosis"
}